Could muscle proteins reveal hidden muscle loss in diabetes and obesity?

NCT ID NCT07703683

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study investigates whether proteins released by muscles, called myokines, can serve as early warning signs or even causes of muscle loss (sarcopenia) in people with metabolic or endocrine conditions like diabetes, obesity, and Cushing syndrome. Researchers will measure myokine levels in blood and muscle tissue from 100 participants and compare them to muscle health. The goal is to better understand why muscle loss occurs in these diseases and find new ways to detect or prevent it.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this research could identify early biomarkers for muscle loss in metabolic diseases, paving the way for targeted treatments or prevention strategies.
What could go wrong
This is an observational study, not a treatment trial, so it will not directly test any therapy. The findings may not lead to immediate clinical applications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CUSHING SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cliniques Universitaires Saint-Luc

    RECRUITING

    Woluwe-Saint-Pierre - Sint-Pieters-Woluwe, 1150, Belgium

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.